drugset / Trial / NCT01483638
Axitinib as Maintenance Treatment in Patients With Metastatic CRC
Phase 2
Terminated
84 enrolled
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the maintenance therapy with axitinib in patients with metastatic colorectal carcinoma
Timeline
- Start
- 2012-02
- Primary completion
- 2015-09
- Completion
- 2015-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Axitinib | Small molecule | 5 mg | Oral |